OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biomarkers of ketamine's antidepressant effect: An umbrella review
Shakila Meshkat, Roger Ho, Bing Cao, et al.
Journal of Affective Disorders (2022) Vol. 323, pp. 598-606
Open Access | Times Cited: 12
Shakila Meshkat, Roger Ho, Bing Cao, et al.
Journal of Affective Disorders (2022) Vol. 323, pp. 598-606
Open Access | Times Cited: 12
Showing 12 citing articles:
Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
Maria Gałuszko‐Węgielnik, Zuzanna Chmielewska, Katarzyna Jakuszkowiak‐Wojten, et al.
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 142-142
Open Access | Times Cited: 14
Maria Gałuszko‐Węgielnik, Zuzanna Chmielewska, Katarzyna Jakuszkowiak‐Wojten, et al.
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 142-142
Open Access | Times Cited: 14
Clinical pharmacological innovation in the treatment of depression
Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 349-362
Closed Access | Times Cited: 13
Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 349-362
Closed Access | Times Cited: 13
Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers
Juliana Lima Constantino, Jens H. van Dalfsen, Sara Massetti, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 136, pp. 111251-111251
Open Access
Juliana Lima Constantino, Jens H. van Dalfsen, Sara Massetti, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 136, pp. 111251-111251
Open Access
National trends and correlates of treatment resistance in major depressive episode and associated suicidal ideation and behaviors among adults in the United States
Taeho Greg Rhee, Tanner J. Bommersbach, Robert A. Rosenheck, et al.
Journal of Affective Disorders (2024) Vol. 358, pp. 342-349
Closed Access | Times Cited: 2
Taeho Greg Rhee, Tanner J. Bommersbach, Robert A. Rosenheck, et al.
Journal of Affective Disorders (2024) Vol. 358, pp. 342-349
Closed Access | Times Cited: 2
Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder
Ke Xu, Shuang Zhao, Yi Ren, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Ke Xu, Shuang Zhao, Yi Ren, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)
Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat, et al.
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access | Times Cited: 2
Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat, et al.
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access | Times Cited: 2
Heart Rate Variability as a Potential Predictor of Response to Intranasal Esketamine in Patients with Treatment-Resistant Depression: A Preliminary Report
Lorenzo Moccia, Giovanni Bartolucci, Maria Pepe, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4767-4767
Open Access | Times Cited: 2
Lorenzo Moccia, Giovanni Bartolucci, Maria Pepe, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4767-4767
Open Access | Times Cited: 2
Anti-inflammatory effects of ketamine in the treatment-resistant depression: a narrative review
Marta Jóźwiak-Bębenista, Paulina Sokołowska, Edward Kowalczyk, et al.
Farmacja Polska (2024) Vol. 79, Iss. 11, pp. 699-709
Open Access
Marta Jóźwiak-Bębenista, Paulina Sokołowska, Edward Kowalczyk, et al.
Farmacja Polska (2024) Vol. 79, Iss. 11, pp. 699-709
Open Access
A retrospective analysis of iv ketamine outcome on hospitalisations in an unselected psychiatric sample
Karl Sandström, Olli Kampman, Peter Asellus
Acta Neuropsychiatrica (2024), pp. 1-7
Closed Access
Karl Sandström, Olli Kampman, Peter Asellus
Acta Neuropsychiatrica (2024), pp. 1-7
Closed Access
Neural correlates of treatment response to ketamine for treatment-resistant depression: A systematic review of MRI-based studies
Je‐Yeon Yun, Yong‐Ku Kim
Psychiatry Research (2024) Vol. 340, pp. 116092-116092
Open Access
Je‐Yeon Yun, Yong‐Ku Kim
Psychiatry Research (2024) Vol. 340, pp. 116092-116092
Open Access
Biomarkers use in psycho-oncology practice: Are we there yet?
Jacynthe Rivest, Christophe Longpré-Poirier, Véronique Desbeaumes Jodoin, et al.
Palliative & Supportive Care (2023) Vol. 21, Iss. 6, pp. 963-966
Open Access | Times Cited: 1
Jacynthe Rivest, Christophe Longpré-Poirier, Véronique Desbeaumes Jodoin, et al.
Palliative & Supportive Care (2023) Vol. 21, Iss. 6, pp. 963-966
Open Access | Times Cited: 1
Uma perspectiva da neurociência sobre a psiquiatria intervencionista
Fernando Campos Barbosa, Francis Moreira da Silveira, Pedro Shiozawa, et al.
Revista de Gestão e Secretariado (Management and Administrative Professional Review) (2023) Vol. 14, Iss. 4, pp. 4540-4554
Open Access
Fernando Campos Barbosa, Francis Moreira da Silveira, Pedro Shiozawa, et al.
Revista de Gestão e Secretariado (Management and Administrative Professional Review) (2023) Vol. 14, Iss. 4, pp. 4540-4554
Open Access
